InvestorsHub Logo
Followers 53
Posts 1783
Boards Moderated 0
Alias Born 03/22/2015

Re: meshcan post# 152045

Thursday, 04/23/2015 7:59:16 AM

Thursday, April 23, 2015 7:59:16 AM

Post# of 403187
Hi Meschan,

We've been debating this issue re: identity of ELI-200. It is interesting that as we were going back and forth on this MB that clinicaltrials.gov was amended by the company to make it less specific. It used to say immediate-release oxycodone in the title and it used to give a dose of 15mg. Not sure what it means that those details were omitted. I have been advocating the idea that ELI-200 may be a novel formulation, specifically, an immediate-release oxycodone with controlled-release features. Pure opinion and speculation, of course, but here are some of my earlier posts that explain my reasoning, based on the earlier version of the trial details:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112279272

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112292755

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112294555

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112300471

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112398538


Have a great day everybody! Buy, hold, accumulate ELTP.

"There are three kinds of lies: lies, damned lies, and statistics."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News